Global Contraceptives Drugs and Devices Market 2023 by Company, Regions, Type and Application, Forecast to 2029
Page: 110
Published Date: 08 Sep 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Contraceptives Drugs and Devices market size was valued at USD 29340 million in 2022 and is forecast to a readjusted size of USD 43250 million by 2029 with a CAGR of 5.7% during review period.
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Contraceptives Drugs and Devices industry chain, the market status of Female (Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives), Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)), Male (Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives), Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Contraceptives Drugs and Devices.
Regionally, the report analyzes the Contraceptives Drugs and Devices markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Contraceptives Drugs and Devices market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Contraceptives Drugs and Devices market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Contraceptives Drugs and Devices industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives), Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Contraceptives Drugs and Devices market.
Regional Analysis: The report involves examining the Contraceptives Drugs and Devices market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Contraceptives Drugs and Devices market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Contraceptives Drugs and Devices:
Company Analysis: Report covers individual Contraceptives Drugs and Devices players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Contraceptives Drugs and Devices This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Female, Male).
Technology Analysis: Report covers specific technologies relevant to Contraceptives Drugs and Devices. It assesses the current state, advancements, and potential future developments in Contraceptives Drugs and Devices areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Contraceptives Drugs and Devices market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Contraceptives Drugs and Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Market segment by Application
Female
Male
Market segment by players, this report covers
Teva Pharmaceutical Industries Ltd
Church & Dwight Co. Inc
Reckitt Benckiser Plc
Pfizer, Inc
Bayer AG
Mayer Laboratories, Inc
The Female Health Company
Cooper Surgical, Inc
Allergan plc
Cipla Limited
Merck & Co. Inc
Veru, Inc
Organon Group of Companies
Agile Therapeutics
TherapeuticsmMD, Inc
Afaxys, Inc
Mithra Pharmaceuticals
Abbvie
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Contraceptives Drugs and Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Contraceptives Drugs and Devices, with revenue, gross margin and global market share of Contraceptives Drugs and Devices from 2018 to 2023.
Chapter 3, the Contraceptives Drugs and Devices competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Contraceptives Drugs and Devices market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Contraceptives Drugs and Devices.
Chapter 13, to describe Contraceptives Drugs and Devices research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Contraceptives Drugs and Devices
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Contraceptives Drugs and Devices by Type
1.3.1 Overview: Global Contraceptives Drugs and Devices Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Contraceptives Drugs and Devices Consumption Value Market Share by Type in 2022
1.3.3 Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
1.3.4 Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
1.4 Global Contraceptives Drugs and Devices Market by Application
1.4.1 Overview: Global Contraceptives Drugs and Devices Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Female
1.4.3 Male
1.5 Global Contraceptives Drugs and Devices Market Size & Forecast
1.6 Global Contraceptives Drugs and Devices Market Size and Forecast by Region
1.6.1 Global Contraceptives Drugs and Devices Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Contraceptives Drugs and Devices Market Size by Region, (2018-2029)
1.6.3 North America Contraceptives Drugs and Devices Market Size and Prospect (2018-2029)
1.6.4 Europe Contraceptives Drugs and Devices Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Contraceptives Drugs and Devices Market Size and Prospect (2018-2029)
1.6.6 South America Contraceptives Drugs and Devices Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Contraceptives Drugs and Devices Market Size and Prospect (2018-2029)
2.1 Teva Pharmaceutical Industries Ltd
2.1.1 Teva Pharmaceutical Industries Ltd Details
2.1.2 Teva Pharmaceutical Industries Ltd Major Business
2.1.3 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Solutions
2.1.4 Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.2 Church & Dwight Co. Inc
2.2.1 Church & Dwight Co. Inc Details
2.2.2 Church & Dwight Co. Inc Major Business
2.2.3 Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Solutions
2.2.4 Church & Dwight Co. Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Church & Dwight Co. Inc Recent Developments and Future Plans
2.3 Reckitt Benckiser Plc
2.3.1 Reckitt Benckiser Plc Details
2.3.2 Reckitt Benckiser Plc Major Business
2.3.3 Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Solutions
2.3.4 Reckitt Benckiser Plc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Reckitt Benckiser Plc Recent Developments and Future Plans
2.4 Pfizer, Inc
2.4.1 Pfizer, Inc Details
2.4.2 Pfizer, Inc Major Business
2.4.3 Pfizer, Inc Contraceptives Drugs and Devices Product and Solutions
2.4.4 Pfizer, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Pfizer, Inc Recent Developments and Future Plans
2.5 Bayer AG
2.5.1 Bayer AG Details
2.5.2 Bayer AG Major Business
2.5.3 Bayer AG Contraceptives Drugs and Devices Product and Solutions
2.5.4 Bayer AG Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bayer AG Recent Developments and Future Plans
2.6 Mayer Laboratories, Inc
2.6.1 Mayer Laboratories, Inc Details
2.6.2 Mayer Laboratories, Inc Major Business
2.6.3 Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Solutions
2.6.4 Mayer Laboratories, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Mayer Laboratories, Inc Recent Developments and Future Plans
2.7 The Female Health Company
2.7.1 The Female Health Company Details
2.7.2 The Female Health Company Major Business
2.7.3 The Female Health Company Contraceptives Drugs and Devices Product and Solutions
2.7.4 The Female Health Company Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 The Female Health Company Recent Developments and Future Plans
2.8 Cooper Surgical, Inc
2.8.1 Cooper Surgical, Inc Details
2.8.2 Cooper Surgical, Inc Major Business
2.8.3 Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Solutions
2.8.4 Cooper Surgical, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Cooper Surgical, Inc Recent Developments and Future Plans
2.9 Allergan plc
2.9.1 Allergan plc Details
2.9.2 Allergan plc Major Business
2.9.3 Allergan plc Contraceptives Drugs and Devices Product and Solutions
2.9.4 Allergan plc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Allergan plc Recent Developments and Future Plans
2.10 Cipla Limited
2.10.1 Cipla Limited Details
2.10.2 Cipla Limited Major Business
2.10.3 Cipla Limited Contraceptives Drugs and Devices Product and Solutions
2.10.4 Cipla Limited Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cipla Limited Recent Developments and Future Plans
2.11 Merck & Co. Inc
2.11.1 Merck & Co. Inc Details
2.11.2 Merck & Co. Inc Major Business
2.11.3 Merck & Co. Inc Contraceptives Drugs and Devices Product and Solutions
2.11.4 Merck & Co. Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Merck & Co. Inc Recent Developments and Future Plans
2.12 Veru, Inc
2.12.1 Veru, Inc Details
2.12.2 Veru, Inc Major Business
2.12.3 Veru, Inc Contraceptives Drugs and Devices Product and Solutions
2.12.4 Veru, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Veru, Inc Recent Developments and Future Plans
2.13 Organon Group of Companies
2.13.1 Organon Group of Companies Details
2.13.2 Organon Group of Companies Major Business
2.13.3 Organon Group of Companies Contraceptives Drugs and Devices Product and Solutions
2.13.4 Organon Group of Companies Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Organon Group of Companies Recent Developments and Future Plans
2.14 Agile Therapeutics
2.14.1 Agile Therapeutics Details
2.14.2 Agile Therapeutics Major Business
2.14.3 Agile Therapeutics Contraceptives Drugs and Devices Product and Solutions
2.14.4 Agile Therapeutics Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Agile Therapeutics Recent Developments and Future Plans
2.15 TherapeuticsmMD, Inc
2.15.1 TherapeuticsmMD, Inc Details
2.15.2 TherapeuticsmMD, Inc Major Business
2.15.3 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Product and Solutions
2.15.4 TherapeuticsmMD, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 TherapeuticsmMD, Inc Recent Developments and Future Plans
2.16 Afaxys, Inc
2.16.1 Afaxys, Inc Details
2.16.2 Afaxys, Inc Major Business
2.16.3 Afaxys, Inc Contraceptives Drugs and Devices Product and Solutions
2.16.4 Afaxys, Inc Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Afaxys, Inc Recent Developments and Future Plans
2.17 Mithra Pharmaceuticals
2.17.1 Mithra Pharmaceuticals Details
2.17.2 Mithra Pharmaceuticals Major Business
2.17.3 Mithra Pharmaceuticals Contraceptives Drugs and Devices Product and Solutions
2.17.4 Mithra Pharmaceuticals Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Mithra Pharmaceuticals Recent Developments and Future Plans
2.18 Abbvie
2.18.1 Abbvie Details
2.18.2 Abbvie Major Business
2.18.3 Abbvie Contraceptives Drugs and Devices Product and Solutions
2.18.4 Abbvie Contraceptives Drugs and Devices Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Abbvie Recent Developments and Future Plans
3.1 Global Contraceptives Drugs and Devices Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Contraceptives Drugs and Devices by Company Revenue
3.2.2 Top 3 Contraceptives Drugs and Devices Players Market Share in 2022
3.2.3 Top 6 Contraceptives Drugs and Devices Players Market Share in 2022
3.3 Contraceptives Drugs and Devices Market: Overall Company Footprint Analysis
3.3.1 Contraceptives Drugs and Devices Market: Region Footprint
3.3.2 Contraceptives Drugs and Devices Market: Company Product Type Footprint
3.3.3 Contraceptives Drugs and Devices Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Contraceptives Drugs and Devices Consumption Value and Market Share by Type (2018-2023)
4.2 Global Contraceptives Drugs and Devices Market Forecast by Type (2024-2029)
5.1 Global Contraceptives Drugs and Devices Consumption Value Market Share by Application (2018-2023)
5.2 Global Contraceptives Drugs and Devices Market Forecast by Application (2024-2029)
6.1 North America Contraceptives Drugs and Devices Consumption Value by Type (2018-2029)
6.2 North America Contraceptives Drugs and Devices Consumption Value by Application (2018-2029)
6.3 North America Contraceptives Drugs and Devices Market Size by Country
6.3.1 North America Contraceptives Drugs and Devices Consumption Value by Country (2018-2029)
6.3.2 United States Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
6.3.3 Canada Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
6.3.4 Mexico Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
7.1 Europe Contraceptives Drugs and Devices Consumption Value by Type (2018-2029)
7.2 Europe Contraceptives Drugs and Devices Consumption Value by Application (2018-2029)
7.3 Europe Contraceptives Drugs and Devices Market Size by Country
7.3.1 Europe Contraceptives Drugs and Devices Consumption Value by Country (2018-2029)
7.3.2 Germany Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
7.3.3 France Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
7.3.5 Russia Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
7.3.6 Italy Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
8.1 Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Contraceptives Drugs and Devices Market Size by Region
8.3.1 Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Region (2018-2029)
8.3.2 China Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
8.3.3 Japan Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
8.3.4 South Korea Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
8.3.5 India Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
8.3.7 Australia Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
9.1 South America Contraceptives Drugs and Devices Consumption Value by Type (2018-2029)
9.2 South America Contraceptives Drugs and Devices Consumption Value by Application (2018-2029)
9.3 South America Contraceptives Drugs and Devices Market Size by Country
9.3.1 South America Contraceptives Drugs and Devices Consumption Value by Country (2018-2029)
9.3.2 Brazil Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
9.3.3 Argentina Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
10.1 Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Contraceptives Drugs and Devices Market Size by Country
10.3.1 Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Country (2018-2029)
10.3.2 Turkey Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
10.3.4 UAE Contraceptives Drugs and Devices Market Size and Forecast (2018-2029)
11.1 Contraceptives Drugs and Devices Market Drivers
11.2 Contraceptives Drugs and Devices Market Restraints
11.3 Contraceptives Drugs and Devices Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Contraceptives Drugs and Devices Industry Chain
12.2 Contraceptives Drugs and Devices Upstream Analysis
12.3 Contraceptives Drugs and Devices Midstream Analysis
12.4 Contraceptives Drugs and Devices Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Contraceptives Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Contraceptives Drugs and Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Contraceptives Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Contraceptives Drugs and Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Teva Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 6. Teva Pharmaceutical Industries Ltd Major Business
Table 7. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Product and Solutions
Table 8. Teva Pharmaceutical Industries Ltd Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Teva Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 10. Church & Dwight Co. Inc Company Information, Head Office, and Major Competitors
Table 11. Church & Dwight Co. Inc Major Business
Table 12. Church & Dwight Co. Inc Contraceptives Drugs and Devices Product and Solutions
Table 13. Church & Dwight Co. Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Church & Dwight Co. Inc Recent Developments and Future Plans
Table 15. Reckitt Benckiser Plc Company Information, Head Office, and Major Competitors
Table 16. Reckitt Benckiser Plc Major Business
Table 17. Reckitt Benckiser Plc Contraceptives Drugs and Devices Product and Solutions
Table 18. Reckitt Benckiser Plc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Reckitt Benckiser Plc Recent Developments and Future Plans
Table 20. Pfizer, Inc Company Information, Head Office, and Major Competitors
Table 21. Pfizer, Inc Major Business
Table 22. Pfizer, Inc Contraceptives Drugs and Devices Product and Solutions
Table 23. Pfizer, Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Pfizer, Inc Recent Developments and Future Plans
Table 25. Bayer AG Company Information, Head Office, and Major Competitors
Table 26. Bayer AG Major Business
Table 27. Bayer AG Contraceptives Drugs and Devices Product and Solutions
Table 28. Bayer AG Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bayer AG Recent Developments and Future Plans
Table 30. Mayer Laboratories, Inc Company Information, Head Office, and Major Competitors
Table 31. Mayer Laboratories, Inc Major Business
Table 32. Mayer Laboratories, Inc Contraceptives Drugs and Devices Product and Solutions
Table 33. Mayer Laboratories, Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Mayer Laboratories, Inc Recent Developments and Future Plans
Table 35. The Female Health Company Company Information, Head Office, and Major Competitors
Table 36. The Female Health Company Major Business
Table 37. The Female Health Company Contraceptives Drugs and Devices Product and Solutions
Table 38. The Female Health Company Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. The Female Health Company Recent Developments and Future Plans
Table 40. Cooper Surgical, Inc Company Information, Head Office, and Major Competitors
Table 41. Cooper Surgical, Inc Major Business
Table 42. Cooper Surgical, Inc Contraceptives Drugs and Devices Product and Solutions
Table 43. Cooper Surgical, Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Cooper Surgical, Inc Recent Developments and Future Plans
Table 45. Allergan plc Company Information, Head Office, and Major Competitors
Table 46. Allergan plc Major Business
Table 47. Allergan plc Contraceptives Drugs and Devices Product and Solutions
Table 48. Allergan plc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Allergan plc Recent Developments and Future Plans
Table 50. Cipla Limited Company Information, Head Office, and Major Competitors
Table 51. Cipla Limited Major Business
Table 52. Cipla Limited Contraceptives Drugs and Devices Product and Solutions
Table 53. Cipla Limited Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cipla Limited Recent Developments and Future Plans
Table 55. Merck & Co. Inc Company Information, Head Office, and Major Competitors
Table 56. Merck & Co. Inc Major Business
Table 57. Merck & Co. Inc Contraceptives Drugs and Devices Product and Solutions
Table 58. Merck & Co. Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Merck & Co. Inc Recent Developments and Future Plans
Table 60. Veru, Inc Company Information, Head Office, and Major Competitors
Table 61. Veru, Inc Major Business
Table 62. Veru, Inc Contraceptives Drugs and Devices Product and Solutions
Table 63. Veru, Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Veru, Inc Recent Developments and Future Plans
Table 65. Organon Group of Companies Company Information, Head Office, and Major Competitors
Table 66. Organon Group of Companies Major Business
Table 67. Organon Group of Companies Contraceptives Drugs and Devices Product and Solutions
Table 68. Organon Group of Companies Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Organon Group of Companies Recent Developments and Future Plans
Table 70. Agile Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Agile Therapeutics Major Business
Table 72. Agile Therapeutics Contraceptives Drugs and Devices Product and Solutions
Table 73. Agile Therapeutics Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Agile Therapeutics Recent Developments and Future Plans
Table 75. TherapeuticsmMD, Inc Company Information, Head Office, and Major Competitors
Table 76. TherapeuticsmMD, Inc Major Business
Table 77. TherapeuticsmMD, Inc Contraceptives Drugs and Devices Product and Solutions
Table 78. TherapeuticsmMD, Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. TherapeuticsmMD, Inc Recent Developments and Future Plans
Table 80. Afaxys, Inc Company Information, Head Office, and Major Competitors
Table 81. Afaxys, Inc Major Business
Table 82. Afaxys, Inc Contraceptives Drugs and Devices Product and Solutions
Table 83. Afaxys, Inc Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Afaxys, Inc Recent Developments and Future Plans
Table 85. Mithra Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 86. Mithra Pharmaceuticals Major Business
Table 87. Mithra Pharmaceuticals Contraceptives Drugs and Devices Product and Solutions
Table 88. Mithra Pharmaceuticals Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Mithra Pharmaceuticals Recent Developments and Future Plans
Table 90. Abbvie Company Information, Head Office, and Major Competitors
Table 91. Abbvie Major Business
Table 92. Abbvie Contraceptives Drugs and Devices Product and Solutions
Table 93. Abbvie Contraceptives Drugs and Devices Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Abbvie Recent Developments and Future Plans
Table 95. Global Contraceptives Drugs and Devices Revenue (USD Million) by Players (2018-2023)
Table 96. Global Contraceptives Drugs and Devices Revenue Share by Players (2018-2023)
Table 97. Breakdown of Contraceptives Drugs and Devices by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Contraceptives Drugs and Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 99. Head Office of Key Contraceptives Drugs and Devices Players
Table 100. Contraceptives Drugs and Devices Market: Company Product Type Footprint
Table 101. Contraceptives Drugs and Devices Market: Company Product Application Footprint
Table 102. Contraceptives Drugs and Devices New Market Entrants and Barriers to Market Entry
Table 103. Contraceptives Drugs and Devices Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Contraceptives Drugs and Devices Consumption Value (USD Million) by Type (2018-2023)
Table 105. Global Contraceptives Drugs and Devices Consumption Value Share by Type (2018-2023)
Table 106. Global Contraceptives Drugs and Devices Consumption Value Forecast by Type (2024-2029)
Table 107. Global Contraceptives Drugs and Devices Consumption Value by Application (2018-2023)
Table 108. Global Contraceptives Drugs and Devices Consumption Value Forecast by Application (2024-2029)
Table 109. North America Contraceptives Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 110. North America Contraceptives Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 111. North America Contraceptives Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 112. North America Contraceptives Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 113. North America Contraceptives Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 114. North America Contraceptives Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 115. Europe Contraceptives Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Europe Contraceptives Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Europe Contraceptives Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 118. Europe Contraceptives Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 119. Europe Contraceptives Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 120. Europe Contraceptives Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 121. Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 122. Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 123. Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 124. Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 125. Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 126. Asia-Pacific Contraceptives Drugs and Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 127. South America Contraceptives Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 128. South America Contraceptives Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 129. South America Contraceptives Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 130. South America Contraceptives Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 131. South America Contraceptives Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 132. South America Contraceptives Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 134. Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 135. Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 136. Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 137. Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 138. Middle East & Africa Contraceptives Drugs and Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 139. Contraceptives Drugs and Devices Raw Material
Table 140. Key Suppliers of Contraceptives Drugs and Devices Raw Materials
List of Figures
Figure 1. Contraceptives Drugs and Devices Picture
Figure 2. Global Contraceptives Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Contraceptives Drugs and Devices Consumption Value Market Share by Type in 2022
Figure 4. Contraceptive Drugs (Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives)
Figure 5. Contraceptive Devices (Male Contraceptive Devices, Female Contraceptive Devices)
Figure 6. Global Contraceptives Drugs and Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Contraceptives Drugs and Devices Consumption Value Market Share by Application in 2022
Figure 8. Female Picture
Figure 9. Male Picture
Figure 10. Global Contraceptives Drugs and Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Contraceptives Drugs and Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Market Contraceptives Drugs and Devices Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 13. Global Contraceptives Drugs and Devices Consumption Value Market Share by Region (2018-2029)
Figure 14. Global Contraceptives Drugs and Devices Consumption Value Market Share by Region in 2022
Figure 15. North America Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 16. Europe Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 17. Asia-Pacific Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 18. South America Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 19. Middle East and Africa Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 20. Global Contraceptives Drugs and Devices Revenue Share by Players in 2022
Figure 21. Contraceptives Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 22. Global Top 3 Players Contraceptives Drugs and Devices Market Share in 2022
Figure 23. Global Top 6 Players Contraceptives Drugs and Devices Market Share in 2022
Figure 24. Global Contraceptives Drugs and Devices Consumption Value Share by Type (2018-2023)
Figure 25. Global Contraceptives Drugs and Devices Market Share Forecast by Type (2024-2029)
Figure 26. Global Contraceptives Drugs and Devices Consumption Value Share by Application (2018-2023)
Figure 27. Global Contraceptives Drugs and Devices Market Share Forecast by Application (2024-2029)
Figure 28. North America Contraceptives Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 29. North America Contraceptives Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 30. North America Contraceptives Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 31. United States Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 32. Canada Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 33. Mexico Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 34. Europe Contraceptives Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 35. Europe Contraceptives Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 36. Europe Contraceptives Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 37. Germany Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 38. France Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 39. United Kingdom Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 40. Russia Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 41. Italy Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 42. Asia-Pacific Contraceptives Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 43. Asia-Pacific Contraceptives Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 44. Asia-Pacific Contraceptives Drugs and Devices Consumption Value Market Share by Region (2018-2029)
Figure 45. China Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 46. Japan Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 47. South Korea Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 48. India Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 49. Southeast Asia Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 50. Australia Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 51. South America Contraceptives Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 52. South America Contraceptives Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 53. South America Contraceptives Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 54. Brazil Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 55. Argentina Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 56. Middle East and Africa Contraceptives Drugs and Devices Consumption Value Market Share by Type (2018-2029)
Figure 57. Middle East and Africa Contraceptives Drugs and Devices Consumption Value Market Share by Application (2018-2029)
Figure 58. Middle East and Africa Contraceptives Drugs and Devices Consumption Value Market Share by Country (2018-2029)
Figure 59. Turkey Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 60. Saudi Arabia Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 61. UAE Contraceptives Drugs and Devices Consumption Value (2018-2029) & (USD Million)
Figure 62. Contraceptives Drugs and Devices Market Drivers
Figure 63. Contraceptives Drugs and Devices Market Restraints
Figure 64. Contraceptives Drugs and Devices Market Trends
Figure 65. Porters Five Forces Analysis
Figure 66. Manufacturing Cost Structure Analysis of Contraceptives Drugs and Devices in 2022
Figure 67. Manufacturing Process Analysis of Contraceptives Drugs and Devices
Figure 68. Contraceptives Drugs and Devices Industrial Chain
Figure 69. Methodology
Figure 70. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Teva Pharmaceutical Industries Ltd Church & Dwight Co. Inc Reckitt Benckiser Plc Pfizer, Inc Bayer AG Mayer Laboratories, Inc The Female Health Company Cooper Surgical, Inc Allergan plc Cipla Limited Merck & Co. Inc Veru, Inc Organon Group of Companies Agile Therapeutics TherapeuticsmMD, Inc Afaxys, Inc Mithra Pharmaceuticals Abbvie
Related Reports
08 Sep 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
